Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 41-50 of 854

More support is needed for the carers of people with schizophrenia, says NICE
The NHS should provide greater help and support to the relatives and carers of people with psychosis or schizophrenia. In wide-ranging updated guidance on treating and managing psychosis and schizophrenia in adults, the National Institute for Health and Care Excellence says carers? needs should be assessed to ensure they get the right level of support.
February 12, 2014

NICE advises much wider use of statins in draft guidance
NICE is recommending that doctors consider many more people to be at risk of heart disease, stroke or peripheral arterial disease. These conditions, collectively known as cardiovascular disease (CVD), cause 1 in 3 of all deaths in the UK.
February 12, 2014

NICE publishes draft guidance on self-monitoring tests for people on long-term anticoagulation therapy
Draft guidance from NICE?s Diagnostics Assessment Programme on 2 technologies for self-monitoring the clotting of blood in people on long-term anticoagulation therapy has been issued for public consultation.
February 6, 2014

New NICE quality standard aims to improve recognition, assessment and availability of treatments for anxiety disorders
NICE has published a quality standard which aims to improve the quality of care and support for children, young people and adults with anxiety disorders.
February 6, 2014

First NICE Medtech Innovation Briefings published
NICE publishes its first Medtech Innovation Briefings today (Tues 4 February) on a range of novel technologies: a device to cool the brain in patients who?ve suffered a heart attack, a system for measuring narrowing of arteries in people with angina, a hydrosurgery device for cleaning wounds and a test to diagnose kidney damage.
February 4, 2014

NICE consults on updated guidance for two lung cancer drugs
NICE, the healthcare guidance body, is currently reviewing existing guidance on the use of erlotinib (Tarceva, Roche Products) and gefitinib (Iressa, AstraZeneca) for treating non-small-cell lung cancer that has progressed after prior chemotherapy (review of NICE technology appraisal guidance 162 and 175).
February 4, 2014

NICE consults on a new spine-straightening device for children with scoliosis
NICE is consulting on its draft medical technology guidance on a device that aims to straighten and lengthen the spine of children with scoliosis ? a curvature of the spine.     The draft guidance supports the case for using the MAGEC system in children aged 2-11 years who have scoliosis, but for whom standard methods to straighten the spine (such as wearing a back brace) have not worked.
January 28, 2014

NICE consults again on decision to recommend new prostate cancer drug
NICE consults again on decision to recommend new prostate cancer drug
January 28, 2014

New NICE advice for local government: Use a lower BMI to help prevent high levels of heart disease and diabetes in people from minority ethnicities
A new NICE briefing to help local authorities reduce the high levels of diabetes and cardiovascular disease in people from African, Caribbean and Asian backgrounds and other minority ethnicities advises a lower body mass index (BMI) of 23 kg/m2 should be used as a trigger to take action in preventing ill health.
January 22, 2014

NICE recommends new treatment option for multiple sclerosis
In final guidance the National Institute for Health and Care Excellence (NICE) has recommended the use of Genzyme?s multiple sclerosis drug teriflunomide (also called Aubagio). The NHS now has a legal obligation to begin funding this treatment for eligible patients within the next 3 months.
January 22, 2014

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.